Podcasts about uom

US futures gained after the Wall St. close as Lutnick suggested Trump could potentially reduce tariffs on Canada and Mexico, perhaps as soon as Wednesday.APAC mixed but with strength in China after data and the Official Growth Report which maintained a growth target of around 5% and pledged measures to boost spending.EUR underpinned by German debt brake reform with the DXY under pressure as a result, Cable hit a YTD peak while NZD was unreactive to Orr resigning.Bunds weighed on by CDU's Merz saying the first results on debt brake reform have been reached with the SPD alongside proposing new instruments and defence exemptions.Fed's Williams said he does not see the need to change policy currently, and described it as "still restrictive" and with the right balance; highlighted UoM inflation data as one to watch.Crude subdued, XAU range bound and Copper gained on China's report; Trump said he received a letter from Zelensky who is ready to come back to the table.Looking ahead, highlights include Swiss CPI, US ADP National Employment, US Factory Orders, ISM Services, China NPC, Fed's Beige Book, BoE Treasury Select Hearing, Speakers including BoE's Bailey, Pill, Taylor and Greene, Supply from UK, Earnings from Telecom Italia, Bayer, Adidas, Sandoz, Abercrombie & Fitch, Foot Locker & Marvell.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

The player interviews continue as I was joined by rising star & 2024 Curtis Cup star Sara Byrne who tees it up this week on the Epson Tour in Florida after winning both status on LET & Epson Tour. Primarily Sara will be focusing for the time being on Epson Tour as she bids on her quest to achieve a life goal dream of becoming a LPGA Tour player. A successful figure at University of Miami Sara was ranked as high as 44th in World Amateur Golf Rankings & is a 2x Irish National Champion. It's been a stellar Amateur career for Sara having at University of Miami she achieved the lowest scoring average in UoM history (70.34), won 2 NCAA D1 Tournaments, participated at World Amateur Team Championship in 2023, competed at 2024 Palmer Cup and would go undefeated in a historic run at 2024 Curtis Cup for GB&I at Sunningdale where she & Augusta National Women's Amateur Champion Lottie Woad would go undefeated in Fourballs & Foursomes while Sara would defeat Catherine Park 3&2 on Sunday Singles.  After Curtis Cup Sara would turn pro and get her professional debut at Rose Ladies Open event on LETAS finishing T13th & would also make the weekend of both La Sella Open (T41st) & Lacoste Ladies Open De France (T28th). At LET Final Q School after 5 gruelling rounds Sara would finish 15th overall to gain her full LET Card for 2025 along with Epson Tour card. In her first start as a LET member Sara would be right into contention even taking the lead at the first event of season at Lalla Meryem Cup eventually finishing T24th.  I wish Sara the best for 2025 on Epson Tour.    Guys be sure to Download via Podbean,  Apple & Spotify! Like & Subscribe it all means a lot 

Ricardo Gelpi, Rector de la Universidad de Buenos Aires, se expresó en una conferencia de prensa sobre la controversia con la SIGEN (Sindicatura General de la Nación). Afirmó: “Nosotros entendemos que la SIGEN no posee las competencias para auditar a las universidades. Esto no significa que nos oponemos a las auditorías. Todo lo contrario, queremos ser auditados todo lo necesario dentro del marco de las leyes." José Fretes, Gerente de la SIGEN, respondió a las críticas en un diálogo con la prensa tras su presentación en la UBA. Indicó: “Desde que se dictó la Ley de Administración Financiera hace 30 años siempre estuvimos ejerciendo nuestro control sobre el conjunto de las universidades. Hay una postura de la UBA que no está replicada en el grueso de las universidades.” Esta declaración subraya la posición de la SIGEN sobre su rol de supervisión. Martín Menem, Presidente de la Cámara de Diputados, se mostró optimista sobre la colaboración legislativa en un diálogo con TN. Afirmó: “Tenemos una coincidencia ideológica casi total, más del 80% o 90% de lo que debatimos en la Cámara. ¿Estamos cerca de ponernos de novios? Sí, yo digo que estamos muy cerca.” Sus palabras reflejan la afinidad entre los distintos bloques legislativos. Jorge Yoma, apoderado de la lista de Ricardo Quintela, reveló en Radio Con Vos que había presentado una demanda ante la Corte Suprema para cobrar deudas del gobierno nacional. Dijo: “Yo como abogado en representación del Estado provincial presenté una demanda ante la Corte Suprema para cobrar ese dinero. Esta reunión con Francos, que venía siendo postergada, me dijo él mismo ‘¿querés venir ahora?'. ¿Cómo le voy a decir que no al jefe de gabinete?” Su declaración subraya la urgencia de la situación financiera de La Rioja. Carlos Bianco, Ministro de Gobierno Bonaerense, se dirigió a la prensa para criticar a Daniel Scioli por la caída en el turismo, afirmando: “Tome nota señor Scioli que nos está haciendo perder 2700 millones de dólares por año con la falta de políticas. Hoy el turismo es una actividad deficitaria.” Su declaración destaca las preocupaciones sobre la gestión actual. Antonio Caló, Ex titular de la UOM, comentó sobre la situación actual de los paros en diálogo con Gelatina, afirmando: “Paro por el paro mismo ya no sirve más. Los muchachos de la CGT están acompañando, están viendo, esperando que aclare.” Esto sugiere un cambio en la estrategia de protesta sindical. Durante la lectura del veredicto contra L-Gante, el juez Ignacio Racca citó una famosa frase de Spiderman, señalando: “Un gran poder conlleva una gran responsabilidad. Se habló mucho de poder en este juicio y un gran poder conlleva una gran responsabilidad.” Esta referencia enfatiza la importancia del papel público y su impacto. Yolanda Díaz, Vicepresidenta Segunda del Gobierno de España, abordó la violencia de género en una conferencia de prensa, diciendo: “Créanme que tuve una de las conversaciones más difíciles de mi vida. Me reconoció actitudes machistas y vejatorias contra las mujeres.” Esto señala la lucha continua contra el machismo en la sociedad. Donald Trump, durante un acto de campaña, pronunció un mensaje incendiario: “Han destruido a un país, no vamos a soportarlo más. ¡Kamala, estás despedida! ¡Fuera de aquí! ¡Fuera!” Su discurso busca galvanizar a sus seguidores en un momento de tensión política. Finalmente, el comediante Tony Hinchcliffe, en un evento de Donald Trump, provocó controversia al afirmar: “Ahora mismo hay literalmente una isla de basura flotante en el medio del océano. Creo que se llama Puerto Rico.” Su comentario generó indignación y refleja la deshumanización presente en ciertos discursos políticos.

Send us a Text Message.Welcome to a special bonus episode! Recorded live at the RCOG Annual Academic Meeting in January 2024, organised by the Blair Bell Research Society. Join us in conversation with Professor Lucilla Poston, co-hosted with the fabulous Dr Neil Ryan (a clinical academic and subspecialty trainee in gynae-oncology). This is also a chance to celebrate the RCOG Annual Academic Meeting and learn a bit more about the Blair Bell Research Society. With thanks to the RCOG and BBRS for permission to share the recording.  Professor Poston's bio:https://www.kcl.ac.uk/people/lucilla-postonProfessor Lucilla Poston CBE is a Professor of Maternal & Fetal Health in the School of Life Course & Population Sciences. Her research spans maternal nutrition, obesity and gestational diabetes with a focus on the short as well as longer term consequences for the health of mother and the child. Approaches include studies in mother -child cohorts and development of pragmatic interventions in pregnancy to improve pregnancy outcome and child health. Her team also interrogate the early life origins of disease through maternal and child electronic health record data linkages.Professor Poston is President of the International Society for Developmental Origins of Health and Disease, an Honorary Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG) and was elected Fellow of the Academy of Medical Sciences in 2009. She was appointed NIHR Senior Investigator, Emeritus in 2017, having succeeded twice in open competition. In 2017, Lucilla was awarded a CBE for services to Women's Health. In 2024 Lucilla was listed by Research.com as being one of the top 1000 female scientists in the world, according to the H Index.Previously Professor Poston was the Tommy's Chair of Maternal & Fetal Health and the Director of the Tommy's Maternal & Fetal Research Unit based at St Thomas' Hospital, and the Head of the School of Life Course & Population Sciences.RCOG Annual Academic Meeting info:The RCOG Annual Academic meeting ‘Save the date' and call for abstracts has just been announced! 6-7 Feb 2025https://rcog.eventsair.com/annual-academic-meeting-feb-2025Dr Neil Ryan's bio:https://www.ed.ac.uk/profile/neilryanNeil is the RCOG Subspecialty Trainee in Gynaecology Oncology at the Royal Infirmary of Edinburgh and a CSO/NES Clinical Lecturer at the University of Edinburgh.He was awarded a personal MRC fellowship to undertake a PhD at the University of Manchester (UoM) which he completed in 2020. His thesis was supervised by Professors Crosbie and Evans.His PhD led to a change in NICE guidelines relating to the testing of womb cancer along with numerous publications, presentations, invited lectures and awards.Neil's work was recognised by a President's Doctorial Scholarship and awarded the UoM's highest postgraduate award: The President's Medal. Neil was recently awarded the William Blair Bell Lecture by the RCOG.British Gynaecological Cancer Society (BGCS) podcast info:https://www.bgcs.org.uk/professionals/new-podcast-series/Podcast information:We have not included any patient identifiable information, and this podcast is intended for professional education rather than patient information (although welcome anyone interested in the field to listen). Please get in touch with feedback or suggestions for future guests or topics: conversationsinfetalmed@gmail.com, or via Twitter (X) or Instagram via @fetalmedcast.Music by Crowander ('Acoustic

Join us for the week's latest headlines and our latest conversations. 00:00:53 - Week of 07-30-2024 Rundown Kareem Jackson - going Buffalo after being suspended twice for unnecessary hits Matthew Judon - not seen at practice since animated talks Roman Wilson - exits practice on a cart John Cominsky - out indefinitely with torn MCL Sean Payton - skips Zach Wilson in QB rotation Caleb Williams - Bears starters will not start in HOF game Robert Saleh - says safe bet is not to play Aaron Rodgers until week 1 Loul Deng turning South Sudan basketball into a threat…..with his own money Achiuwa returns to Knicks on 1-year, $6M deal 4-point play, Wemby's 8-0 run Key France OT win to Japan 94-90 00:31:09 - 07-31-2024 Rundown DJ Moore - reaches 4-year, $110M extension, largest in franchise history dAvon Godchaux - 2-year extension $21M Jonah Jackson - out for preseason with a bruised scapula New York Jets - Aaron Rodgers and Garrett Wilson downplay animated discussions Dwayne “The Rock” Johnson - Army seeks to recoup $6M in deal with UFL NFL to test Hawk-Eye for line to gain in some preseason games Quinn Bailey - fractures ankle at practice Jeffrey Simmons - apologizes for run-in with radio host Sources:  Grizz bring back Kennard on $11M deal Tatum started for Team USA after DNP in opener, beats South Sudan 103-86 Cavs' Allen to sign 3-year, $91M max extension 01:02:51 - 08-01-2024 Rundown Mental Health Alert - Clyde Edwards-Helaire discusses struggles with PTSD Tarik Cohen - ends NFL comeback attempt, retires. D'Onta Foreman - set to be released from hospital Justin Herbert - diagnosed with plantar fascia injury Matthew Judon - meets with coach Jerod Mayo amid dispute Tristan Wirfs - agrees to $140.6M extension. Highest paid offensive lineman in NFL history John Mara - no regrets about Daniel Jones contract DeAndre Hopkins - knee injury - out 4-6 weeks. Gordon Hayward retires after 14 seasons Sources:  Statue of Kobe with Gigi to be unveiled Famous USA jersey numbers 01:22:26 - 08-05-2024 Rundown Federal judge rules to overturn jury's $4.7B verdict in class action lawsuit filed by “Sunday Ticket” subscribers Texans - Bears game terminated in the 3rd quarter due to severe weather Tyreek Hill - and the Miami Dolphins reconstructed deal worth $90M over the next 3-years with $65M guaranteed Houston Texans - plans to start players in 2nd preseason game Jordan Addison - officially charged with DUI. Hearing on Oct. 7 Geno Smith - returns to practice from knee and hip injuries Harrison Butker - NFL's top-paid kicker at a 4-year extension $25M with $17.74M guaranteed Cam Sample - out for the year with torn Achilles Matthew Judon - explains his side of spat with Jerod Mayo Za'Darius Smith - carted off field with knee contusion Jim Harbaugh - ‘was not aware of any wrongdoing' in violations at UOM. Kobe & GiGi statue revealed Kobe's Staples Center locker sells for record $2.9M --- Support this podcast: https://podcasters.spotify.com/pod/show/double-take-sports-talk/support

Inspiring Stories 045 - Professor Angela Davies - Client Story Subscribe to the Women In STEM Career & Confidence Podcast on your favourite platform and stay tuned. Ang holds a dual role at The University of Manchester as a Professor in Healthcare Science & Education and as an academic leadership position within a strategic cross-institutional change programme, leading on transformational lifelong learning. In this episode we talk about: Fierce prioritisation through discernment of priorities, how to say no, and delegation Effective communication strategies for senior leadership teams How to influence without authority Connect with Ang LinkedIn: Professor Ang Davies  Flexible Learning at UoM: https://www.manchester.ac.uk/discover/teaching-and-learning-excellence/flexible-learning/ PGCert Clinical data Science: https://www.manchester.ac.uk/study/masters/courses/list/20306/pgcert-clinical-data-science/ Digital interventions for genomics and genetics education, empowerment, and service engagement. A systematic review: https://link.springer.com/article/10.1007/s12687-023-00648-w Kickstart your Intentional Careers Journey: Take the Career Accelerator Scorecard: https://scorecard.intentional-careers.com/strategy Register for a free Intentional Careers workshop: https://intentional-careers.com/workshop/ Read The Book 'Intentional Careers for STEM Women' Connect with Hannah Website: hannahnikeroberts.com LinkedIn: Hannah Roberts Coaching  Facebook: Dr Hannah Roberts X (Twitter) @HannahNikeR Instagram @drhannahroberts

Prof. Olga Onuch has written what has been described as the definitive portrait of Volodymyr Zelensky, an extraordinary book called “The Zelensky Effect”. In this book, she explains the paradox of Zelensky as a leader and but also entertainer, businessman and risk-taker. She explores Ukraine's national history to show how its now-iconic president reflects the hopes and frustrations of the country's first ‘independence generation'. Interweaving social and political background with compelling episodes from Zelensky's life and career, this is the story of Ukraine told through the journey of one man who has come to symbolise his country, and perhaps uniquely in the world is forced to make decisions that are existential to the survival of his country. ---------- Prof. Olga Onuch is Professor (Chair) in Comparative and Ukrainian Politics at the University of Manchester (making her the first-ever holder of a Full Professorship in ‘Ukrainian Politics' in the English-speaking world). Olga joined UoM in 2014, after holding research posts at the University of Toronto, the University of Oxford, and Harvard University. ---------- BOOKS: The Zelensky Effect by Olga Onuch, Henry E. Hale, et al. (2023) ---------- LINKS: https://olgaonuch.com/ https://twitter.com/oonuch https://research.manchester.ac.uk/en/persons/olga.onuch https://en.wikipedia.org/wiki/Olga_Onuch https://www.linkedin.com/in/olga-olya-ola-onuch-0163a944/ https://www.hurstpublishers.com/profile/olga-onuch/ ---------- ARTICLES: https://www.foreignaffairs.com/ukraine/zelenskys-fight-after-war https://globalaffairs.org/commentary-and-analysis/podcasts/zelensky-effect-how-ordinary-ukrainian-became-extraordinary-leader https://www.thestar.com/opinion/contributors/the-zelenskyy-effect-why-ukraine-s-ze-is-defeating-russia-s-z/article_aac3affa-3e24-50f8-8c67-626ecc794e95.html ---------- SUPPORT THE CHANNEL: https://www.buymeacoffee.com/siliconcurtain https://www.patreon.com/siliconcurtain ---------- ARTICLES: https://www.telegraph.co.uk/books/non-fiction/best-books-ukraine-russia-2023/ https://granta.com/soundscape-of-war/ https://www.nybooks.com/articles/2022/12/08/ukrainian-lessons-at-the-train-station-ada-wordsworth/ https://www.theoldie.co.uk/article/language-lessons-in-ukraine-ada-wordsworth ---------- TRUSTED CHARITIES ON THE GROUND: kharpp - Reconstruction project supporting communities in Kharkiv and Przemyśl https://kharpp.com/ Save Ukraine https://www.saveukraineua.org/ Superhumans - Hospital for war traumas https://superhumans.com/en/ UNBROKEN - Treatment. Prosthesis. Rehabilitation for Ukrainians in Ukraine https://unbroken.org.ua/ Come Back Alive https://savelife.in.ua/en/ Chefs For Ukraine - World Central Kitchen https://wck.org/relief/activation-chefs-for-ukraine UNITED24 - An initiative of President Zelenskyy https://u24.gov.ua/ Serhiy Prytula Charity Foundation https://prytulafoundation.org NOR DOG Animal Rescue https://www.nor-dog.org/home/ ---------- WATCH NEXT: Operator Starsky https://youtu.be/TEeR3-W7p9s Anna Danylchuk https://youtu.be/XQJoTAAfxt4 Mykola Kuleba https://youtu.be/Ih_EWo9GjUA Olena Halushka https://youtu.be/zbKR18583BY Halyna Yanchenko https://youtu.be/WbjhSlGDKGk ---------- PLATFORMS: Twitter: https://twitter.com/CurtainSilicon Instagram: https://www.instagram.com/siliconcurtain/ Podcast: https://open.spotify.com/show/4thRZj6NO7y93zG11JMtqm Linkedin: https://www.linkedin.com/in/finkjonathan/ Patreon: https://www.patreon.com/siliconcurtain ---------- Welcome to the Silicon Curtain podcast. Please like and subscribe if you like the content we produce. It will really help to increase the popularity of our content in YouTube s algorithm. Our material is now being made available on popular podcasting platforms as well, such as Spotify and Apple Podcasts.

Hosts Chandra and Paul start with a tribute to a valued member of the JDE Community, Andy Klee. Continuing with Andy's passion of education, they discuss a variety of topics focused on JD Edwards (JDE) terminology and its applications, making it a valuable listen for newbies and veterans alike in the JD Edwards community. Encouraging the audience to play along with a game of Lingo Bingo, they cover terms like, Fastpath, Batch and Interactive Versions, Processing Options, Data Dictionary, Notifications and much more.  Throughout the episode, the hosts share several insights regarding topics like the importance of UDCs, the personalization capabilities with UDOs, and details on JDE releases, updates and ESUs. Finally, in an attempt to help their audience fill their bingo boards, they rattle off a series of common JDE acronyms including, SIGs, RUGs, AAI, DMAI, JSI, UOM, OGL, UPK, LMS, and MOS? If you want to deepen your understanding of JD Edwards and enjoy some laughs along the way, don't miss this episode!00:00  Tribute to Andy Klee 04:00  Play JD Edwards lingo bingo, have fun! 10:16  Use watchlist and notifications for smooth operations. 13:58  Form control elements. 15:01  Form types have consistent elements.  18:18  Troubleshooting user issues with report execution details. 23:19  Data dictionary defines and controls system attributes. 25:09  User Defined Objects are empower JD Edwards customers. 29:58  CNC terms, tools and concepts 32:14  Cross reference is valuable for indentifying data usage. 36:37  Unit of measure, the primary unit is important. 38:30  My Oracle support provides various useful resources. 41:44  Midwesternism of the Day! 

European equities are firmer taking impetus from gains on Wall Street; US equity futures are in the green, outperformance in the NQ post-earnings from Amazon (+6%) and Meta (+16.7%).Dollar is around flat awaiting impetus from US NFP; Aussie outperforms recouping the prior day's downside.Bonds are softer giving back recent advances as attention turns to key US dataCrude is firmer and finds some reprieve after hefty losses in the prior session; Gold stands pat alongside a flat DollarLooking ahead, US NFP, Durable Goods, UoM, Earnings from Regeneron, Gilead, Exxon, Chevron, Aon & Abbvie.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

APAC stocks mostly took impetus from the gains on Wall St where stocks were underpinned amid a softer yield environment.US equity futures were boosted after-hours following the big tech earnings (META +15%, AMZN +7%, AAPL -3%).European equity futures indicate a higher open with Euro Stoxx 50 future +0.8% after the cash market closed down 0.2% on Thursday.DXY sits around the 103 mark, AUD is attempting to recoup lost ground, other majors are broadly steady.Al Jazeera initially posted on X that Qatar said Israel agreed to a ceasefire proposal and Hamas gave positive confirmation. However, the post was later deleted.Looking ahead, highlights include US NFP, Durable Goods, UoM, Earnings from Unicredit, Regeneron, Gilead, Qualcomm, Exxon, Chevron, Aon & Abbvie.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

In this episode of our Week Ahead podcast series, we look at the main themes driving global markets over the coming week. In the US (02:29), we have retail sales, industrial production and UoM consumer expectations. In Europe (06:57), it's the Germany ZEW survey, ECB December meeting minutes, UK labour market and CPI data. Then it's the latest from Asia (10:40), with China GDP, PBoC, BI and BOT policy decisions, Japan CPI, as well as global markets all to discuss.

  Coris 360, ANSTO, finding a lost radioactive source in the outback @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} We Talk to Lachlan Chartier about the Coris 360 from ANSTO, and the amazing story about how they found a lost radioactive source in the outback@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}  nuccast,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu, ,ansto,corlis360,cancer,radioactive,PET,safety,physics,waste @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  Coris 360, ANSTO, finding a lost radioactive source in the outback @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} We Talk to Lachlan Chartier about the Coris 360 from ANSTO, and the amazing story about how they found a lost radioactive source in the outback@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}  nuccast,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu, ,ansto,corlis360,cancer,radioactive,PET,safety,physics,waste @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  Coris 360, ANSTO, finding a lost radioactive source in the outback @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} We Talk to Lachlan Chartier about the Coris 360 from ANSTO, and the amazing story about how they found a lost radioactive source in the outback@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}  nuccast,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu, ,ansto,corlis360,cancer,radioactive,PET,safety,physics,waste @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  Coris 360, ANSTO, finding a lost radioactive source in the outback @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} We Talk to Lachlan Chartier about the Coris 360 from ANSTO, and the amazing story about how they found a lost radioactive source in the outback@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}  nuccast,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu, ,ansto,corlis360,cancer,radioactive,PET,safety,physics,waste @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  Michael Hofman, LuTectom, Violet and more theranostics for Prostate cancer Prof Michal Hofman from Peter Mac talks to us about new theranostics in prostate cancer @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}  nuccast,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu, ,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,Petermac,prostate @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  Michael Hofman, LuTectom, Violet and more theranostics for Prostate cancer Prof Michal Hofman from Peter Mac talks to us about new theranostics in prostate cancer @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}  nuccast,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu, ,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,Petermac,prostate @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  Michael Hofman, LuTectom, Violet and more theranostics for Prostate cancer Prof Michal Hofman from Peter Mac talks to us about new theranostics in prostate cancer @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}  nuccast,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu, ,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,Petermac,prostate @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  Michael Hofman, LuTectom, Violet and more theranostics for Prostate cancer Prof Michal Hofman from Peter Mac talks to us about new theranostics in prostate cancer @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}  nuccast,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu, ,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,Petermac,prostate @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

In this episode of our Week Ahead podcast series, we look at the main themes driving global markets over the coming week. In the US (01:50), we have CPI, PPI, the NFIB, UoM sentiment and FOMC minutes. In Europe (11:53), it's the Sentix survey, the ECB minutes, UK RICs and BOE credit conditions, Sweden and Norway CPI. Then it's the latest from Asia (18:16), with China and India CPI, China FX reserves, credit data, Japan BOP, PPI, the BOJ opinion survey as well as macro notes of the week all to discuss (05:56).

In this episode of our Week Ahead podcast series, we look at the main themes driving global markets over the coming week. In the US (01:56), we have PCE, durable goods and regional surveys from the Richmond, Chicago and Dallas Fed along with UoM inflation expectations. In Europe (06:03), it's Euro Area flash inflation, German unemployment and IFOs, UK GDP, mortgage approvals and nationwide house prices, Sweden PPI and economic tendency, Norges FX purchases and unemployment too. Then we discuss China PMIs (12:16), and the latest from Asia (23:33), with the BOT meeting, Caixin PMIs, BOJ minutes, Tokyo, Singapore, HK and Australia CPI, Japan and Australia retail sales, and NZ business confidence.

 NET theranostic nursing to the outbackWe chat to an amazing nurse who is coordinating complex theranostic treaments to patients accross a vast area encompasing outback Australia. She works as a neuroenocrine theranostic cordinator from Queen Elizabeth hospital in South Australia. anzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PETanzsnm2023,nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,nursing,Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 NET theranostic nursing to the outbackWe chat to an amazing nurse who is coordinating complex theranostic treaments to patients accross a vast area encompasing outback Australia. She works as a neuroenocrine theranostic cordinator from Queen Elizabeth hospital in South Australia. anzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PETanzsnm2023,nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,nursing,Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 NET theranostic nursing to the outbackWe chat to an amazing nurse who is coordinating complex theranostic treaments to patients accross a vast area encompasing outback Australia. She works as a neuroenocrine theranostic cordinator from Queen Elizabeth hospital in South Australia. anzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PETanzsnm2023,nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,nursing,Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 NET theranostic nursing to the outbackWe chat to an amazing nurse who is coordinating complex theranostic treaments to patients accross a vast area encompasing outback Australia. She works as a neuroenocrine theranostic cordinator from Queen Elizabeth hospital in South Australia. anzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PETanzsnm2023,nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,nursing,Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

In this episode of our Week Ahead podcast series, we look at the main themes driving global markets over the coming week. In the US (01:56), we have Jackson Hole, durable goods, flash PMIs and UoM sentiment. In Europe (08:40), it's flash PMIs, Norway and German GDP, German IFOs, and German producer prices. Then it's the latest from Asia (14:56), with the Bank of Korea, Bank Indonesia, China LPR, Singapore and Tokyo CPI as well as global markets all to discuss.

Joanna Bronowicka, owner of Well Bred, The Healthy Pet Marketplace, is a passionate and knowledgeable pet retailer with six locations in New Jersey. Originally from Poland, Joanna came to the United States to pursue an MBA at the University of Michigan. During her studies, Joanna developed a proposal for a pet boutique that focused on premium products and pet adoptions. After completing her degree at UOM, she worked in the corporate sector and as time passed she found herself drawn back to her college project. While searching for options to enter into the pet industry a friend informed Joanna that Well Bred, a pet store established in 2001, was up for sale. Seeing it as a great opportunity to start her own business, Joanna relied on her business experience to analyze the next steps and took the plunge into the world of entrepreneurship. With her academic blueprint and passion for pet nutrition, Joanna transformed Well Bred into a store that prioritizes healthy nutrition and high-quality products for dogs and cats. To further enhance her knowledge, Joanna enrolled in feline and canine nutrition courses at Southern Illinois University.  Joanna Bronowicka wanted to be a CEO and she is doing it!! Listen & learn about Joanna's views on customers, pet foods, sustainability, DCM, and more. --- Send in a voice message: https://podcasters.spotify.com/pod/show/tazz-thepetropolist/message

In this episode of our Week Ahead podcast series, we look at the main themes driving global markets over the coming week. In the US (01:46), we have CPI, PPI, NFIB, consumer lending data, the UoM and the trade balance. In Europe (09:40), it's the Euro Area Sentix survey, Norway CPI, Swiss FX reserves and the ECB's consumer expectations survey. Then it's the latest from Asia (18:33), with the RBI meeting, China CPI and lending data, the BOJ's MPM opinion summary as well as global macro notes of the week all to discuss (04:57).

 From the Alzheimers International meeting the De Leon imaging prize winners 2023We talk to the three imaging prize winners at the Alzheimers international meeting.At the most eventful brain imaging meeting ever where AD therapies are announced we talk to the 3 main imaging prize winners.https://aaic.alz.org/about/awards.asp#dlnuccast.com,NIF,UOM,nuclearmedicine,radioactive,mbciu,lund,BiomedicineInstitute,NIF,nuclearmedicine,brain,aaic,radioactive,mbciu,PET,imaging, alzheimers,AD,LATE,amyloid,TDP-43,TAUPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 From the Alzheimers International meeting the De Leon imaging prize winners 2023.We talk to the three imaging prize winners at the Alzheimers international meeting.At the most eventful brain imaging meeting ever where AD therapies are announced we talk to the 3 main imaging prize winners.https://aaic.alz.org/about/awards.asp#dlnuccast.com,NIF,UOM,nuclearmedicine,radioactive,mbciu,lund,BiomedicineInstitute,NIF,nuclearmedicine,brain,aaic,radioactive,mbciu,PET,imaging, alzheimers,AD,LATE,amyloid,TDP-43,TAUPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 From the Alzheimers International meeting the De Leon imaging prize winners 2023We talk to the three imaging prize winners at the Alzheimers international meeting.At the most eventful brain imaging meeting ever where AD therapies are announced we talk to the 3 main imaging prize winners.https://aaic.alz.org/about/awards.asp#dlnuccast.com,NIF,UOM,nuclearmedicine,radioactive,mbciu,lund,BiomedicineInstitute,NIF,nuclearmedicine,brain,aaic,radioactive,mbciu,PET,imaging, alzheimers,AD,LATE,amyloid,TDP-43,TAUPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 From the Alzheimers International meeting the De Leon imaging prize winners 2023.We talk to the three imaging prize winners at the Alzheimers international meeting.At the most eventful brain imaging meeting ever where AD therapies are announced we talk to the 3 main imaging prize winners.https://aaic.alz.org/about/awards.asp#dlnuccast.com,NIF,UOM,nuclearmedicine,radioactive,mbciu,lund,BiomedicineInstitute,NIF,nuclearmedicine,brain,aaic,radioactive,mbciu,PET,imaging, alzheimers,AD,LATE,amyloid,TDP-43,TAUPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

Picture the immense amount of energy invested in analyzing your emotional responses to every social interaction, striving to decipher not only your own feelings but also how the other person perceived the conversation. Or imagine navigating through life with a constant undercurrent of irritability and anxiety, yet lacking a clear understanding of their origin. These experiences only represent a small fraction of what people with alexithymia may experience. Alexithymia, which in simple terms is difficulty identifying and describing emotions, is a trait that is often associated with autism and ADHD, however despite the fact that one-in-ten people in the general population have this trait (not just Autistic people), there are still many misconceptions about what it is, who it really impacts, and how it shapes their experiences and relationships. Dr. Megan Anna  Neff, an AuDHD psychologist with alexithymia, states that a lot of things that have been attributed to autism, for example, difficulty with emotion recognition on faces or voice, are actually due to alexithymia, not autism.  In this episode of Divergent Conversations, Patrick Casale and Dr. Megan Anna Neff, talk with guest, Thomas Henley, an Autism consultant, public speaker, workplace trainer, and podcast host of “Thoughty Auti Podcast”, about all things alexithymia. Top 3 reasons to listen to the entire episode: Understand what alexithymia is, how is it related to autism and ADHD, and some common attributes associated with autism that are strongly linked to alexithymia. Identify the ways that alexithymia affects emotional regulation and the ability to connect with others on a deep emotional level. Learn what strategies and therapeutic approaches individuals with alexithymia can use to help facilitate emotional regulation and deeper connections with others. Alexithymia affects many individuals in the general population, so taking the time to recognize and understand the traits, challenges, and experiences associated with alexithymia, can help facilitate deeper connections with others, self-acceptance, and healthy ways to manage overwhelming emotions and situations. Alexithymia Resources Alexithymia articles on neurodivergent insights: https://neurodivergentinsights.com/blog/category/Alexithymia Alexithymia workbook: https://neurodivergentinsights.com/neurodivergentstore/p/alexithymia-workbook Dr. Neff's Alexithimia Training: https://learn.therasmarts.com/courses/Alexithymia More about our guest, Thomas Henley: My name is Thomas Henley, I'm an Autism consultant, public speaker and workplace trainer running the Worlds Top podcast ‘Thoughty Auti Podcast', all about Autism & Mental Health - independently presented, edited and promoted by my Autistic self. I'm also a Commonwealth/British champion in Taekwondo, Biomedical Sciences (Hons) graduate from UoM, Autistic Model, documentary creator of ‘Aspergers In Society' & ambassador for Anna Kennedy OBE & Born Anxious. I was diagnosed Autistic at 10 years old and later developed severe mental health conditions at the age of 14 due to trauma at Secondary School - Clinical Depression, GAD, Bulimia & multiple Dissociative disorders. Most of my content focuses around the low quality-of-life statistics for autistic people, such as mental health, social isolation, unemployment, education, relationship difficulties & self-harm in all forms. I've delivered this information to the government, leaders in SEN education, and the general public through my outreach and social media work. My passion is to help people, it's my meaning to life, my saviour for helping me stay around. My ultimate goal is to improve things for future generations who may just experience the same awful things I have.  My content is informed from many angles. During my time at university, I also studied and researched into Autism, Mental Health, Sociology, Psychology, Socialising, Relationships & Philosophy. I also used to be Special Needs TA, I work alongside charities regularly, talk to researchers, Autistic influencers, authors & parents regularly on my podcast, and currently work full-time for a National Inclusion charity. Check out Thomas' resources and content: Thomas' Website: https://thomashenley.co.uk/ Thoughty Auti Podcast (Spotify): https://open.spotify.com/show/6vjXgCB7Q3FwtQ2YqPjnEV?si=BjFjTN9RRm-mG5r4kmxmVQ  Twitter: https://twitter.com/ThomasHenleyUK  YouTube: https://www.youtube.com/c/ThomasHenley  Instagram: https://www.instagram.com/thomashenleyuk/  TikTok (@thomashenleyuk): https://www.tiktok.com/@thomashenleyuk   Transcript PATRICK CASALE: Hey, everyone, you're listening to another episode of Divergent Conversations Podcast. I'm your cohost, Patrick Casale, joined today by Dr. Megan Neff, and Thomas Henley, who is the host of the Thoughty Auti Podcast. So, guest number one on our podcast.  And Megan and I just released on Friday, and the response has been fantastic, feedback has been fantastic. And we're both overwhelmed as hell, is that right Meg? MEGAN NEFF: Yeah, that's right. We were talking before on air how we're both in scatterbrain today. So, that'll make for a fun conversation or something. PATRICK CASALE: Yep. And I definitely just, like, steamrolled through the intro and didn't even let Megan introduce herself, so sorry. MEGAN NEFF: I know. I was like leaning in too, but actually, I- PATRICK CASALE: Thank God I saw it. I'm sorry for that. Thomas, we appreciate you being here and just making the time. We know you're six hours ahead of me and nine hours ahead of Meg. And I think we're going to talk about alexithymia today. And I think we're also going to talk about whatever the hell is going on in our lives and making us feel so scattered. So, thank you for being here. THOMAS HENLEY: Of course, I think you might have mentioned it, but I wasn't totally aware that I was your first guest on the podcast. So, I'm honored very much, so… PATRICK CASALE: No pressure whatsoever. Megan, alexithymia is a topic that is near and dear to your heart. You talk about it often on your Instagram account, Neurodivergent Insights. And you have tons of resources. So, I would love for you to start us off with why it feels important and why we're talking about that today. MEGAN NEFF: Yeah, yeah. Okay, I'll try to pull thoughts together, cohesion. Here we go. Yeah, so I think it's a really relevant topic to autistic and ADHDers, particularly, just because we tend to be more impacted by it.  So, first, just to do my, like, definition of terms, and then go into it, it's actually not a diagnosis. Sometimes people will DM me about like, how do I get diagnosed with this? It's not a diagnosis, it's a personality trait. And it's fairly common. One in 10 people have it. And it's difficulty identifying and describing emotions.  So, one in 10 people in the general population have it. Among autistic people, it's about 50% or higher. And then among ADHDers, you know, these studies, there's so much variance, but I've seen, like, between 20 to 45%. And then even those who don't have like, full threshold, they have more alexithymic traits.  And this really makes things like emotion regulation, connecting with other people on kind of that deep emotional level a lot more difficult.  The other interesting thing about alexithymia is that a lot of things that have been attributed to autism, like difficulty with emotion recognition on faces, or voice, empathy, which autism and empathy is a whole topic, that's huge. All these things, they've done studies, and when they pull out autistic people with alexithymia, and autistic people without alexithymia, autistic people without alexithymia are doing as well as the control group.  So, a lot of the things that we've said that's an autistic thing is actually… that's a severe alexithymia thing. So, that, to me, when I read that I was like, this explains why so many people aren't getting diagnosed, for one.  For two, when a person is autistic with alexithymia there's some higher support needs around emotional regulation, emotional identification. I actually have alexithymia. Because of my training, I would say I now have pretty mild alexithymia and I've figured out how to adapt to it. But I definitely see how difficulty identifying emotions through my life has led to some hard stuff. So, yeah, that's the clinical definition.  Thomas, I'm curious to hear, like, you're really interested in this topic. Where did that curiosity come from? THOMAS HENLEY: I think it's because I have quite a bit of a history with like, emotions. Like, ever since I was very young I was pretty much fascinated by neurotypicals. I was kind of doing, like, the reverse autism specialist thing. I had the fascination of neurotypical people.  And I remember from, sort of, early days, sort of, at school, I would look at people around me, people, particularly, during like high school, secondary school age, and they would be doing things with no reason or rhyme to why they're doing it, but they just seemed to have something in their brain that, like, flicked a switch, and then they went, and did something.  I now know that, you know, for example, things like dancing, it's not a social display that you're like, "I'm going to do a social display." It's a thing that you do because it feels good, and people feel driven to do things that feel good.  And I found that really confusing because I used to analyze the reasons behind a lot of my decision-making. And I think it's, I was reading a book recently, I can't remember the reference, but they were talking about how emotions can be quite a big feed into how we make decisions. So, it could be something as simple as food. You know, you eat something, and then you like, no, you're picking between, like, a cupcake, and like some protein pancakes, and you model eating both of those in your brain, detects how you feel from eating those in that model, and then kind of use your emotions to probably get the cupcakes.  So, I think there's a lot of depth to it and a lot of the issues that I had, particularly, in secondary school was emotional dysregulation, a lot of mental health difficulties, but also, not really as much of an ability to notice when my anxiety or my depression was getting worse, and, you know, psychologist's, therapists, they'd give me these anxiety worksheets, but the issue with that is that you first got to know that you're in your anxious [CROSSTALK 00:06:44]. MEGAN NEFF: Exactly, exactly. Yeah, yeah, I talked about that when I do trainings on this of, like, we go from like one, or two, to 10, or at least that's our experience, we're not actually doing that. But we're not picking up, you know, that like emotion thermometer or that stress thermometer, we're not picking up the subtle increase. And so, that's what leads to those big emotional outbursts. They can also look very, like, borderline or bipolar, which is another reason that I think we get misdiagnosed because it's so hard to regulate your emotions if you're not registered, and you're angry, or stressed, or anxious till it's out of 10. PATRICK CASALE: Yeah, and then society's kind of perceiving you, and not how you're attending to react to things as well, and that inability to regulate is so challenging in social situations, but it's challenging in a lot of environments like in the workplace, for example. Like, if you're unable to identify your emotions, that can lead to a lot of workplace conflict as well. And I think that's another reason that we see so many neurodiverse people struggling with neurotypical jobs and environments, is just they're not set up to be successful in a lot of ways and they're not set up to be affirmative. THOMAS HENLEY: It's quite key for, like, enforcing boundaries and stuff like because a lot of people they kind of get a… someone says something that makes them upset, or angry, they kind of get a bit of an emotional jolt to kind of be like, "Hey, actually, that's not okay." Whereas, in a lot of cases in my life, and, you know, from talking to other people, it seems that we just kind of take it, and then we go away and think about it, and come back like a week later, a couple of days later like, "Actually, hey, this isn't good." And I think it can sometimes lead a lot of neurotypicals to not really trust, like, our reactions to things in, like, the present. MEGAN NEFF: Yeah, that is so well said. It can cause so much relationship confusion because the person with alexithymia whether you're ADHD, autistic, or neurotypical, like, we need that space to process, I think. So, reflective emotions is when we're bringing in our prefrontal cortex.  I think a lot of us overcompensate for the fact that we're not feeling those more in-the-moment fleeting emotions by becoming really good at reflective emotions. But that takes time and space. And often, we can't do that in an emotionally charged space. So, like, if we're having a, for example, emotionally charged conversation with our partner, we're going to have a really hard time accessing our emotions in that moment until we take some space, and especially, if your partner's more anxiously attached, that space is going to feel like abandonment. And this is where I see a lot of relationships kind of go off the rails, is that dance that kicks up around that. PATRICK CASALE: Yeah, that makes a lot of sense. And I think, you know, you and I are both in the mental health profession. So, I think there's advanced training that goes on behind the scenes, right? Where we're like, okay, now we're starting to identify these emotions, now I'm starting to become more familiar with how I'm feeling, and experiencing, how I'm moving through the world.  Not everyone has that luxury, and privilege, and ability to do, so I think it becomes very murky, very confusing. And that's where you start to see a lot of dissociation, and disconnection, and that really frustration, isolation, loneliness paradox that kicks in in social environments. And I think that is so fucking hard for people when it feels so painful to identify what is really happening beneath the surface. MEGAN NEFF: Mm-hmm (affirmative.) THOMAS HENLEY: I think one of the best ways that I found it to like describe what it's like to be electrifying to neurotypicals is like a threshold-related condition. Like, most people, if we put a quantitative number on anxiety levels from like zero to 100, you know, perhaps a lot of neurotypicals they'd be able to tell within the 20 to 50% range that they are at a certain level of anxiety whereas when you're autistic, and you have alexithymia that might be 70, 80, 90%.  And a lot of those strategies that we learn to calm ourselves down, I found the most use in like preventative things and like blanket approaches to solving when I was younger, and I didn't really understand it.  And it also led to, as he was saying about sort of disassociation, I actually did a lot of reading about it. And it was something that I noticed even when I was very young. And so, I looked into that kind of thing and I was like, "Hey, I have situations in my life where, for some reason, in 10, 15 minutes I feel like a completely different person, I feel differently in my body, I perceive the world differently, I behave differently, I must be a different person." And so, I looked into this dissociative identity disorder, and I was like, "Hey, this is actually what's happening." Because I couldn't feel the emotion. And I had to, like, go through, and just look at all the science, and the terminology, and the philosophy behind different emotions, and really trying to embed that in order to understand it in the future.  But I used to have, like, different colors, which, obviously, the colors were related to emotions. But at that time, it just didn't click for me at all. MEGAN NEFF: I think that captures something really important. Yeah, and it's interesting. Like, I don't know what is dissociation, what is alexithymia here, but one thing I notice among autistic people, in general, is a much more, like, fragmented view of self.  And so, when you describe that of like, looking into DID… Like, that's actually, I feel, like probably pretty common for a lot of autistic people to look into DID or I'm seeing a lot more about plural systems now because it can be such a fragmented experience when we can't access our emotions, even more so. PATRICK CASALE: Megan, I'm curious about, just in your own life, when you're experiencing alexithymia and kind of the identification, like you're mentioning being fragmented, right? You and I have talked about fragmentation a lot and just feeling so, like there's so many pieces here, and you can always identify or connect them, and how that really is, you know, showing up these days for you, in terms of like, you've built an audience, you've built a presence, you, obviously, have such a wonderful reputation. And I know you and I talk of this off the air about like, when you're feeling really heavy or like when you're really in that space of teaching and researching it can be disconnecting from how you're experiencing day-to-day too. MEGAN NEFF: I actually think I feel the most connected when I'm in my head. And that's part of the problem is it's so hard to be in my body, which I've talked about plenty. So, when I'm in research flow or writing I feel like the most like myself. It's all the other places I occupy that I'm… And right, like that's actually a really common experience with special interests. We often feel most like ourselves when are immersed in our special interest.  PATRICK CASALE: Absolutely.  MEGAN NEFF: And can access emotions. Like, I see that with my clients, when we start talking about special interests, there's an animation that pops up. Like, we access emotions more easily. Thomas, you were about to say something. THOMAS HENLEY: Yeah, I just find it interesting you're talking about, like, feeling fragmented because before I came across the concept of alexithymia I did a video and like a post called like, My Split Brain. And it was, basically, talking, I found this book called, I think, The Monkey Mind.  MEGAN NEFF: Yeah, yes.  THOMAS HENLEY: Which is, yeah. And I really- MEGAN NEFF: Go ahead and explain it though because I know what you're talking about, but our listeners don't. THOMAS HENLEY: Yeah, it's like, basically, splitting your brain into, sort of, the higher cognitive kind of prefrontal cortex that uses intellectual things, and logic, and facts, and things to dissect and understand your environment whereas the monkey mind is the emotional brain, like things related to like the amygdala, and drives, and desires, and needs that are important to survival.  And the whole book is kind of about framing it as that you do have kind of these two pulling forces. One is like your willpower and your, I guess, more human side. And the other side is like the emotional kind of monkey side.  But I found that really interesting. And I felt like it was probably one of the first things that I related to, in terms of thinking about my emotions because I did feel for a long time that I just couldn't, like facts, and dates, and events just seem to be like, ridiculously hard to connect them in my brain. Even if they are apparently clear, the feelings that I have from that event don't feel like they connect with that.  And so, I'll got a lot of situations where I've had really bad experience during the day. And then for some reason, I'll just be alone, I feel a bit anxious, and I feel a bit down. Now, why is that happened? And, obviously, I know that something bad's happened in the day, but it just doesn't immediately link. It's like after connecting neuro- MEGAN NEFF: Yeah.  THOMAS HENLEY: …pathways together. MEGAN NEFF: Yeah, it's not an automatic process. It's like, okay, I've got to analyze. Yeah, yeah. When I started therapy, like five years ago, one of the things my therapist said to me was like, "You are so like analytical or like, aware." But almost, it wasn't a criticism, but it was a curiosity of like, and it was an interesting moment for me. Like, isn't everyone doing this all day long? Just like analyzing the shit out of their day, trying to figure out why am I feeling this way? And that was a really interesting moment for me because I could tell he was struck by like, how analytical I was about my experience. PATRICK CASALE: It would be nice to know what it would be like to move through the world without analyzing every experience and thing that fucking happens to me, that would be fantastic. It would feel like a yes, maybe, like a pressure relief in a way. But it's just so challenging to move away from that. Like, I have to analyze everything. I'm constantly, like you said, Thomas, can try to connect like, where's this anxious feeling coming from? Oh, yeah, this thing happened to me today, or this thing happened yesterday. And now it's creating these feelings that I can't always associate together. And then, ultimately, it leaves you a bit confused because you can recognize the somatic sensation in your body of like, "I'm feeling anxious." Where is this coming from? Like, why is this feeling so intense right now? Oh, yeah, this thing happened six hours ago. That should create anxiety, but in the moment was not able to connect the dots. THOMAS HENLEY: And that is quite a heavy tendency for, I think, autistic, maybe even neurodivergents as well, but I can only speak from the autistics' perspective, that it is kind of hard to make those… God my brains gone. MEGAN NEFF: Oh, we get it. THOMAS HENLEY: What were you saying, Patrick?  PATRICK CASALE: Oh, just connecting those dots, you know, and those associations where-  THOMAS HENLEY: Yes.  PATRICK CASALE: Yeah. THOMAS HENLEY: It's gone on me, sorry. PATRICK CASALE: That's okay. I think, you know, this is actually nice to see while we're all sitting here because the three of us mentioned we're all feeling a bit scattered today. And it's interesting, like, we're having a very real experience around this conversation. And I can see Megan being very deep in thought when I'm talking, and I'm paying attention to that at my peripheral.  But, you know, I think, there's a paradox for me as a autistic ADHDer where association with emotion, and feeling and trying to name it and define it versus like, constant sensory seeking and stimulation seeking, and like, really trying to seek out that intensity as well, and then trying to like connect the dots with intensity seeking to soothe the anxiety in your body. It's really an interesting experience for me. And soccer has been so helpful. Thomas, I know you're really into fitness for that, probably, a similar reason. And [CROSSTALK 00:21:37]-  THOMAS HENLEY: … proprioceptive stimming. PATRICK CASALE: I know, I know. I was talking to Megan about proprioceptive stim the other day and needing to have my, like soul, and body crushed back into my body, and how often I feel the need for that. I asked my wife to do that the other day, and she looked at me, and was like, "The fuck are you talking about?" And I was like, "I just need you to do it. Like, I'll explain it to you later. But I need you to do that." And I think that's a very, very typical experience for me on almost a daily basis. THOMAS HENLEY: I think that there is a tendency sometimes… I've remembered what I was going to say. I think that there's a tendency sometimes with autistic people that we need to know the reasons for things. And sometimes in a lot of cases you don't always need to now. Like, it could be useful in some cases to know why you're feeling a certain way. And sometimes it might just be, you know, good to just chalk it up to possible stresses, like mental health or so, where it plays things being too productive, not getting enough rest due to special interests.  And I think sometimes getting in my head about how I'm feeling stops me from like focusing on other things that I'm doing, that are helping with my stress, and my emotions. So, unless I'm feeling sort of a deep, aching issue, or that, you know, it's perhaps related to a relationship or a friendship, or if I'm having quite bad mental health crises or lows, then it's useful for me to go for and pick that. So, there's that. And I also think that creator autism from the inside, we were talking about alexithymia on my podcast, and we were saying that can be quite a large burden for using your, like, higher cognitive brain to do things that are quite simple, or quick, or emotional based like social communication. So, it really made me kind of think about, you know, like, how much effort am I putting into situations that don't really matter in the grand scheme of things? That kind of mentality. MEGAN NEFF: I really like how you're balancing kind of the autistic need to know because I agree that's super regulated when I can pinpoint to like, oh, this is why I'm feeling that way. I say it calms my amygdala down, just calms everything down.  THOMAS HENLEY: Fixated at the core. MEGAN NEFF: But balancing out... What did you say? THOMAS HENLEY: Fixated at the core. MEGAN NEFF: Yes, yes.  THOMAS HENLEY: It's the reason that everything will be okay. It's like when you get really stressed about finishing a task on the computer and the programs aren't working. It's like, really easy to get that done, and then, you'll be okay whereas sometimes [CROSSTALK 00:24:45]- MEGAN NEFF: Well, I think it's [INDISCERNIBLE 00:24:56] partly because it just produces uncertainty. Like, it's like, okay, I can track why I'm feeling that way. But what I really like is how you balance it with acceptance.  For me, in my training to become a psychologist, I probably did a bulk of my training in motor therapy called acceptance commitment therapy or ACT, which is all about kind of accepting our emotions. It doesn't mean we have to like them, but accepting they exist and then asking, "Okay, but how do I continue to move toward what matters to me, to move toward my values?" And that was probably one of the best things for my anxiety, was learning an element of acceptance. It was yes, sometimes I can locate like, okay, my routine's off, this, that's why I'm anxious today. Other times I can't and it is about that, "Okay, how am I going to hold this and live with this and continue to move toward what matters to me and not let it completely derail my day?" THOMAS HENLEY: It's prioritization, I think, the way you put your energy and so… MEGAN NEFF: Yeah. PATRICK CASALE: Yeah, I think you make a great point, Thomas, about that because I do think a lot of autistic people are using a ton of cognitive energy to really figure out meaning behind everything. And it's just unbelievably exhausting.  And Megan, you and I have talked about, like, replenishing, and trying to like recharging and being able to soothe, but sometimes it's really challenging to replenish that energy, and then you're playing catch up all the time. And I think that's why so many of us are just going through the world feeling really, really exhausted all the time.  And I like your example, Megan, with acceptance and commitment therapy, and, you know, I've talked about, like, IFS, as well, internal family systems. And that has been very helpful for me to have like parts work because I can't always identify what's happening in the moment, or what I'm experiencing, or how I'm feeling. And if we're getting really cognitive, I really can't identify it then. But if I can break it into parts, like a part of me is feeling overwhelmed, and it's okay for that to show up, and I'm going to accept that, and I don't need to find out the meaning of why. I just need to accept that it exists.  And there are other parts of me that are feeling okay or feeling more grounded. And that's been pretty remarkably life-changing, if I'm being really honest about it like that work has been so tremendously supportive in the last few years. THOMAS HENLEY: I think it was really important to mention the aspect to, like, the certainty around things because I feel like it's kind of weird because if you study neurotypicals, like I have, and just discovered this, like, so obsessed with understanding what's going on in their brains, I think there's a lot of situations where we give ourselves a hard time for not understanding certain things. Like, neurotypicals tend to talk a lot about things like read the room, and understand the hidden meaning, and understand things just from the flow of the conversation.  But from my experience, particularly, in the workplace, or within friend groups, a lot of people that you talk to individually after those big sort of group conversations, they have completely different ideas of what's gone on. And I felt like, you know, we do have that drive to try and find that certainty out, specifically, like, around emotions and social things which are inherently so uncertain and emotional. It can be kind of hard for us. And it's kind of one of those things that I think a lot of neurotypicals they go with what they feel from the situation. And then, that's the truth.  But compare and contrast each person in a certain group conversation, it's completely different. It's just that we like to know exactly what happened, and exactly what people are wanting, and exactly what they're trying to say. MEGAN NEFF: There's a TV show called The Affair. I don't know if either of you have watched it, but I've found it so interesting because… and I think there's maybe a few shows that do this, but they, like, really lean into it, the first season, at least, where you see this exact same episode but from different people's perspectives.  And so, like, the characters will be wearing different clothes and different people's memories. And it's just so interesting, that idea of subjectivity, of everyone's experience of the same conversation, and then how it encodes in memory is wildly different, which is, frankly, terrifying for me. And someone who is anchored in like facts and logic of like, how did you get that from this conversation? But brains are weird. And the way we experience something is so heavily filtered by our past experiences, our beliefs, our biases. It's wild and terrifying. THOMAS HENLEY: Definitely agree.  MEGAN NEFF: Like, all of us are going to walk away from this 40 minutes we spent together with different memories, different experiences. PATRICK CASALE: And probably our own different- THOMAS HENLEY: Perspectives. PATRICK CASALE: Yeah, exactly. Different perspectives and interpretations, right? Because I'm the type of person who will walk away and analyze like, was that a good conversation? Did it feel meaningful? Did I show up the way I wanted to show up? All of those things will be running through my mind the rest of the day. So, yeah, it's just really interesting. Brains are weird. MEGAN NEFF: I'll actually be having similar questions. I'll also be like, why was I so foggy during that conversation? What was happening? Like, I'll also be thinking about, like, the relational dynamics, but also like, will that be it? Was that cohesive enough for a podcast? Was that a meaningful experience for Thomas? Was that worth his time to have him on? Yeah. PATRICK CASALE: Yeah, yeah. THOMAS HENLEY: I can confirm for [INDISCERNIBLE 00:31:17] certainty that it's a meaningful experience. I love chatting to you. And it's really nice to chat to you Patrick, as well. PATRICK CASALE: Thank you. Is this our awkward transition goodbye time because that's how I'm reading the interview [INDISCERNIBLE 00:31:32]. THOMAS HENLEY: I don't know how you guys wrap things up, so- PATRICK CASALE: We don't always- MEGAN NEFF: Do we want to say anything about where to find Thomas' work? And then wrap up? PATRICK CASALE: Yeah, Thomas, if you'd love to share with the audience where they can find you or what you're doing in the world, and what you're putting out there. THOMAS HENLEY: Sure, you can find my podcasts, the Thoughty Auti Podcast on YouTube, Spotify, any of the podcasting streaming services, or you can check out my Instagram page @thomashenleyuk where I make daily posts and about two reels a day, autism related. PATRICK CASALE: Your Instagram account is awesome. I mean, I found your stuff because Megan was on your podcast, and shared some of that, and I was watching, and really, really cool stuff, a lot of information, a lot of humor thrown in which I really enjoy, and a lot of really cool perspective. So, really appreciate just being able to have this time together and spend the last 40 minutes talking about all of this. THOMAS HENLEY: Thank you very much, Patrick.  PATRICK CASALE: You're welcome. THOMAS HENLEY: I appreciate that. PATRICK CASALE: To everyone who is listening to the Divergent Conversations Podcast, new episodes are out every single Friday on all major podcast platforms. Like, download, subscribe, and share. And goodbye.

Bad AI is becoming a major headache for organizations. Tech is a male-dominated sphere, which means that it produces, inherently, male-skewed AI driven by unconsciously biased datasets. The effects of this can be measurable. Run through the same AI, women can receive worse credit or loan agreements than their male counterparts, be pushed out from job openings, receive worse medical treatment, or even receive performance penalties for doing the same work as men to the same standard. So how has this situation emerged and, more importantly, what can be done about it?

 Guillem Pratx from Stanford PhD clever single cell imaging for everyone!We chat to an A Prof Pratx from Stanford who's team has made possible single cell nuclear medicine imaging for under $100. nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,SNNMI,nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,imaging,stanfordPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 Guillem Pratx from Stanford PhD clever single cell imaging for everyoneWe chat to an A Prof Pratx from Stanford who's team has made possible single cell nuclear medicine imaging for under $100. nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,SNNMI,nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,imaging,stanfordPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 Guillem Pratx from Stanford PhD clever single cell imaging for everyoneWe chat to an A Prof Pratx from Stanford who's team has made possible single cell nuclear medicine imaging for under $100. nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,SNNMI,nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,imaging,stanfordPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 Guillem Pratx from Stanford PhD clever single cell imaging for everyone!We chat to an A Prof Pratx from Stanford who's team has made possible single cell nuclear medicine imaging for under $100. nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,SNNMI,nuccast.com,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,mbciu,PET,imaging,stanfordPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 Amazing Physics (and Chem) of Pb212 Simon Puttick from AdvancellToday we talk about a completely amazing new theranostic tracer Pb212 and how we saw physics usually physics only seen at CERN in a PET scan. Crazy.anzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,physics,mbciu,PETanzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,physics,mbciu,PETPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 Amazing Physics (and Chem) of Pb212 Simon Puttick from AdvancellToday we talk about a completely amazing new theranostic tracer Pb212 and how we saw physics usually physics only seen at CERN in a PET scan. Crazy.anzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,physics,mbciu,PETanzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,physics,mbciu,PETPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 Amazing Physics (and Chem) of Pb212 Simon Puttick from AdvancellToday we talk about a completely amazing new theranostic tracer Pb212 and how we saw physics usually physics only seen at CERN in a PET scan. Crazy.anzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,physics,mbciu,PETanzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,physics,mbciu,PETPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

 Amazing Physics (and Chem) of Pb212 Simon Puttick from AdvancellToday we talk about a completely amazing new theranostic tracer Pb212 and how we saw physics usually physics only seen at CERN in a PET scan. Crazy.anzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,physics,mbciu,PETanzsnm2023,nuccast.com,advancell,NIF,UOM,nuclearmedicine,theranostics,cancer,radioactive,physics,mbciu,PETPlease let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

In this episode of our Week Ahead podcast series, we look at the main themes driving global markets over the coming week. In the US (01:43) we have the debt ceiling, FOMC minutes, core PCE and UoM. In Europe (11:40), it's the big flash PMI week, consumer confidence, IFOs and UK CPI and retail sales. Then it's the latest from Asia (19:20) with the RBNZ, BI and BOK meetings, Tokyo CPI, as well as the macro notes of the week to discuss (08:16). 

While there are several process manufacturing solutions out there, they all differ in their capabilities. Some are designed for growers and processors, while others are friendlier for distributors and DTC companies. The process manufacturing verticals have unique nuances, such as the hierarchy of serial and lot numbers. The serial numbers need to be managed at the UoM, case, and license plate levels. The pharma distribution may also have requirements such as DSD and route accounting with e-signature required for the delivery and then e-signature required at each process step for pharma compliance. So where does ECi Deacom fit, and how is it different from the other process manufacturing solutions in the market?In today's episode, we invited a panel of industry experts for a live discussion on LinkedIn to conduct an independent review of ECi Deacom's capabilities. We covered many grounds, including their depth with pharma and process manufacturing capabilities with features such as lot and serial number traceability, DSD accounting, recipe, and nutrition label printing. We also covered some of their weaknesses, such as multi-entity accounting and rigid structure for their chart of accounts.For more information on growth strategies for SMBs using ERP and digital transformation, visit our community at wbs.rocks or elevatiq.com. To ensure that you never miss an episode of the WBS podcast, subscribe on your favorite podcasting platform. 

In this episode of our Week Ahead podcast series, we look at the main themes driving global markets over the coming week. In the US it's PCE inflation, consumer confidence, GDP, Chicago PMI, Dallas Fed and UoM inflation expectations. In Europe it's Flash CPI, German IFOs, UK mortgage approvals and Sweden's economic tendency survey. Then it's the latest from Asia with China PMIs, the BOT, Australia and Tokyo CPI, as well as global markets all to discuss.

In this episode of our Week Ahead podcast series, we look at the main themes driving global markets over the coming week. In the US, we have the FOMC minutes, PCE, UoM, Chicago Fed PMIs and GDP. In Europe it's flash PMI week, will the growth rebound continue? As well as ZEWs, IFOs, consumer confidence and UK CBI trends. Then it's the latest from Asia with Japan CPI, the RBNZ and the BOK meetings all to discuss.

In this episode of our Week Ahead podcast series, we'll be looking at the main themes that will drive global markets over the coming week. In the US it's arguably the most important event of the month with US CPI, the NFIB survey and UoM sentiment. In Europe it's the Sentix survey, industrial production, UK BRC retail sales and the trade balance. Then it's Australian and China inflation, China trade data, their COVID-19 moves and the current state of global markets all to discuss.

Resumen de noticias de la mañana de LA NACION del 1 de noviembre de 2022: Buscan cerrar acuerdos de precios antes de diciembre; terminó la etapa de alegatos en la causa Vialidad; Cristina Kirchner será parte de un acto de la UOM

How much of an impact might UoM conversions have on an ERP implementation? Well, if you asked a seasoned guy who has been part of a large implementation, UoM conversions fire back pretty bad. In fact, at times, they could be a make or break for the ERP implementations. The UoM conversions not supported the way your business processes are structured could be the birth of ad-hoc and excel-based processes. So what are the pitfalls when it comes to UoMs? How to find the UoMs that will be a bottleneck to your implementation and processes?In today's episode, we invited a panel of cross-functional experts for a live interview on LinkedIn who brings significant expertise to discuss UoM conversions business processes best practices. We covered many grounds, including concepts such as sales, consumption, purchase, and usage-based unit of measure and their interactions as you process different transactions. Finally, we covered the differences in the unit of measure best practices across several industries, the impact of the unit of measure on SKUs, and how the inconsistencies across different systems might impact the unit of measure.For more information on growth strategies for SMBs using ERP and digital transformation, visit our community at wbs.rocks or elevatiq.com. To ensure that you never miss an episode of the WBS podcast, subscribe on your favorite podcasting platform.